Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Miñarro et al., 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/204060

Lenalidomide Stabilizes Protein-Protein Complexes by Turning Labile Intermolecular H-Bonds into Robust Interactions

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Targeted protein degradation is a promising therapeutic strategy, spearheaded by the anti-myeloma drugs lenalidomide and pomalidomide. These drugs stabilize very efficiently the complex between the E3 ligase Cereblon (CRBN) and several non-native client proteins (neosubstrates), including the transcription factors Ikaros and Aiolos and the enzyme Caseine Kinase 1 (CK1,), resulting in their degradation. Although the structures for these complexes have been determined, there are no evident interactions that can account for the high efficiency of formation of the ternary complex. We show that lenalidomide's stabilization of the CRBN-CK1 complex is largely due to hydrophobic shielding of intermolecular hydrogen bonds. We also find a quantitative relationship between hydrogen bond robustness and binding affinities of the ternary complexes. These results pave the way to further understand cooperativity effects in drug-induced protein-protein complexes and could help in the design of improved molecular glues and more efficient protein degraders.

Citació

Citació

MIÑARRO LLEONAR, Marina, BERTRAN-MOSTAZO, Andrea, DURO GÓMEZ, Jorge, BARRIL ALONSO, Xavier, JUÁREZ JIMÉNEZ, Jordi. Lenalidomide Stabilizes Protein-Protein Complexes by Turning Labile Intermolecular H-Bonds into Robust Interactions. _Journal of Medicinal Chemistry_. 2023. Vol. 66, núm. 9, pàgs. 6037-6046. [consulta: 30 de gener de 2026]. ISSN: 0022-2623. [Disponible a: https://hdl.handle.net/2445/204060]

Exportar metadades

JSON - METS

Compartir registre